LSTA Earnings LISATA THERAPEUTICS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.50 | 2026-05-11 | 10-Q |
| FY 2024 | 2025-12-31 | -1.91 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -1.58 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.09 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.55 | 2026-05-11 | 10-Q |
| FY 2024 | 2024-12-31 | -2.40 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -1.85 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.26 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.65 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -2.58 | 2025-02-27 | 10-K |
| Q3 2024 | 2023-09-30 | -1.92 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.28 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.77 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -10.47 | 2024-02-29 | 10-K |
| Q3 2023 | 2022-09-30 | -11.28 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -2.69 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.05 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -7.45 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -5.76 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.27 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.